Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 4876  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1
E. Keller,Ö Yaldizli,T. Bombeli
.2008;()255
[DOI]
2
Jan Drappatz,Patrick Y.C. Wen
.2011;()55
[DOI]
3Protamine reversal of low molecular weight heparin
Joost J. van Veen,Rhona M. Maclean,Kingsley K. Hampton,Stuart Laidlaw,Steve Kitchen,Peter Toth,Mike Makris
Blood Coagulation & Fibrinolysis.2011;22(7)565
[DOI]
4Rapid Reversal of Warfarin-Associated Hemorrhage in the Emergency Department by Prothrombin Complex Concentrates
Kenneth Frumkin
Annals of Emergency Medicine.2013;62(6)616
[DOI]
5Pharmacologic Interventions for the Management of Critical Bleeding
Stacy Voils
Pharmacotherapy.2007;27(9 Part 2)69S
[DOI]
6Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study
R. Demeyere,S. Gillardin,J. Arnout,P. F. W. Strengers
Vox Sanguinis.2010;99(3)251
[DOI]
7Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
B. LAURITZEN,U. HEDNER,P. B. JOHANSEN,M. TRANHOLM,M. EZBAN
Journal of Thrombosis and Haemostasis.2008;6(5)804
[DOI]
8A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach
Mallory R. Scola,Leslie M. Baggesen,Tim C. Nichols,Nigel S. Key,Caterina M. Gallippi
Thrombosis Research.2012;129(5)S57
[DOI]
9Medical Management of Brain Tumor Patients
Jan Drappatz,David Schiff,Santosh Kesari,Andrew D. Norden,Patrick Y. Wen
Neurologic Clinics.2007;25(4)1035
[DOI]
10What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?
Rachel P. Rosovsky,Mark A. Crowther
Hematology.2008;2008(1)36
[DOI]
11On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers
Manuel D. Carcao,Kathryn E. Webert
Seminars in Hematology.2008;45(1)S68
[DOI]
12Coagulation factor VIIa (recombinant) in nonhemophilic patients requiring neurosurgery
Colleen M. Culley,Susan Guttendorf,Megan Coldren,Susan J. Skledar,Paige R. Gross,Richard M. Spiro,Darrell J. Triulzi,Margaret V. Ragni
American Journal of Health-System Pharmacy.2009;66(17)1554
[DOI]
13Newer antithrombotic drugs
Pranav Sikka,V.K. Bindra
Indian Journal of Critical Care Medicine.2010;14(4)188
[DOI]
14Newer antithrombotic drugs
Adriana Cajiao
Journal of Medical and Biological Engineering.2011;31(2)129
[DOI]
15Medical Care of Patients With Brain Tumors
Jan Drappatz
CONTINUUM: Lifelong Learning in Neurology.2012;18(2)275
[DOI]
16The Practical Management of Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy
Luca Masotti,Mario Di Napoli,Daniel A. Godoy,Daniela Rafanelli,Giancarlo Liumbruno,Nicholas Koumpouros,Giancarlo Landini,Alessandro Pampana,Roberto Cappelli,Daniela Poli,Domenico Prisco
International Journal of Stroke.2011;6(3)228
[DOI]
17The role of recombinant-activated factor VII in bleeding trauma patients
Richard P Dutton,Bianca M Conti
Current Opinion in Anaesthesiology.2009;22(2)299
[DOI]
18Gastrointestinal Bleeding in the Setting of Anticoagulation and Antiplatelet Therapy
Kassem Barada,Heitham Abdul-Baki,Ihab I. El Hajj,Jana G. Hashash,Peter H. Green
Journal of Clinical Gastroenterology.2009;43(1)5
[DOI]
19Gastrointestinal Bleeding in the Setting of Anticoagulation and Antiplatelet Therapy
Harold R. Roberts,Dougald M. Monroe,Nigel S. Key
Journal of Clinical Gastroenterology.2008;43(1)587
[DOI]
20Surgical Management of Severe Spontaneous Hemorrhage of the Abdominal Wall Complicating Acenocoumarol Treatment
Orestis Ioannidis,George Paraskevas,Anastasios Kotronis,Stavros Chatzopoulos,Athina Konstantara,Nikolaos Papadimitriou,Apostolos Makrantonakis,Emmanouil Kakoutis
Acta Medica (Hradec Kralove, Czech Republic).2012;55(1)47
[DOI]
21Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
Walter Ageno,David Garcia,Maria I. Aguilar,James Douketis,Guido Finazzi,Davide Imberti,Alfonso Iorio,Nigel S. Key,Wendy Lim,Marco Marietta,Domenico Prisco,Ravi Sarode,Sophie Testa,Alberto Tosetto,Mark Crowther
American Journal of Hematology.2009;84(9)584
[DOI]
22Use of rFVIIa in two children presenting major bleeding not controlled by the usual treatments before emergent surgery
Eliane Guyot,Aude Carillion,Marie-Laurence Poli-Mérol,Isabelle Ferrand,Philippe Chauvet,Philippe Nguyen,Jean-Marc Malinovsky
Pediatric Anesthesia.2008;18(12)1226
[DOI]
23Guideline on the management of bleeding in patients on antithrombotic agents
Mike Makris,Joost J. Van Veen,Campbell R. Tait,Andrew D. Mumford,Mike Laffan
British Journal of Haematology.2013;160(1)35
[DOI]
24Recombinant Activated Factor VII Use in Critically III Patients: Clinical Outcomes and Thromboembolic Events
Gretchen M Brophy,Christina L Candeloro,Jaime R Robles,Donald F Brophy
Annals of Pharmacotherapy.2013;47(4)447
[DOI]
25Management and monitoring of large enoxaparin overdose treated with protamine
Michael Chan,Anselm Wong
Emergency Medicine Australasia.2020;32(4)712
[DOI]
26Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature
Kelly L. West,Cory Adamson,Maureane Hoffman
Journal of Neurosurgery.2011;114(1)9
[DOI]
27Anticoagulation-Related Intracranial Hemorrhages
Manoj K. Mittal,Alejandro A. Rabinstein
Current Atherosclerosis Reports.2012;14(4)351
[DOI]
28Pharmacology and therapeutic uses of antiplatelet drugs
E. Osuch Osuch,T.L. Rasakanya Rasakanya
South African General Practitioner.2020;1(3)101
[DOI]
29Polyphosphate as a general procoagulant agent
S. A. SMITH,J. H. MORRISSEY
Journal of Thrombosis and Haemostasis.2008;6(10)1750
[DOI]
30Use of recombinant factor VIIa (NovoSeven®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux
P. Luporsi,R. Chopard,S. Janin,E. Racadot,Y. Bernard,F. Ecarnot,MF. Séronde,F. Briand,A. Guignier,V. Descotes-Genon,N. Meneveau,F. Schiele
Acute Cardiac Care.2011;13(2)93
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow